Takeda Pharmaceutical Cash Flow Statement
View: Annual
| Dec 06+ | Mar 05 | Mar 04 | |
|---|---|---|---|
| Net Operating Cash Flow | -- | 2,747.9 | 2,945.1 |
| Net Investing Cash Flow | -- | (672.3) | (1,318.8) |
| Net Financing Cash Flow | -- | (687.2) | (561.8) |
| Net Change in Cash | -- | 1,529.7 | 502.9 |
| Depreciation & Amortization | -- | 290.3 | 265.8 |
| Capital Expenditures | -- | (499.0) | (512.7) |
| Cash Dividends Paid | -- | (697.0) | (576.2) |
